90PFlowcytometric Expression of LAIR-1 Inhibitory Immune-Receptor in Pediatric Acute Lymphoblastic Leukemia Cases Does Not Correlate With Standard Risk Factors and Minimal Residual Disease

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdx711.071
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Minimal Residual Disease in Childhood B Lymphoblastic Leukemia and Its Correlation With Other Risk Factors

Pakistan Journal of Medical Sciences
Medicine
2019English

Transcriptome Analysis of Minimal Residual Disease in Subtypes of Pediatric B Cell Acute Lymphoblastic Leukemia

Clinical Medicine Insights: Oncology
Oncology
2015English

Minimal Residual Disease Quantification by Flow Cytometry Provides Reliable Risk Stratification in T-Cell Acute Lymphoblastic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2018English

Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients With Earlier Quantification of Minimal Residual Disease

PLoS ONE
Multidisciplinary
2013English

Immunophenotypic Modulation of the Blast Cells in Childhood Acute Lymphoblastic Leukemia Minimal Residual Disease Detection

Folia Medica
Medicine
2016English

Cross-Sectional Physician Survey on the Use of Minimal Residual Disease Testing in the Management of Pediatric and Adult Patients With Acute Lymphoblastic Leukemia

Hematology
Hematology
2018English

Immunologic Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia: A Comparative Approach to Molecular Testing

Best Practice and Research in Clinical Haematology
OncologyClinical Biochemistry
2010English

High-Risk Pediatric Acute Lymphoblastic Leukemia: To Transplant or Not to Transplant?

Biology of Blood and Marrow Transplantation
TransplantationHematology
2011English

Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy